Close Menu

Somalogic

NEW YORK (GenomeWeb News) – Somalogic said this week that it has received additional funding from the Bill & Melinda Gates Foundation for the development and validation of tuberculosis biomarker assays based on its Somamer technology.

Somalogic said this week that it has named Dan Muehl as chief financial officer.

While its diagnostic ambitions continue to progress slowly, proteomics firm Somalogic appears to be carving out a substantial market for its SOMAscan protein biomarker discovery platform, generating $10.5 million in revenues from the product in 2013.

SAN FRANCISCO (GenomeWeb News) – The 32nd Annual JP Morgan Healthcare Conference kicked off here Monday with several life science tools and diagnostic firms making presentations to investors and other attendees.

SomaLogic has named Byron Hewett as CEO. Hewett takes replaces Larry Gold, who will continue serving the Boulder, Colo.-based company as chairman of the board. Gold will also work as a full-time adviser, SomaLogic said.

Somalogic this week named Byron Hewett CEO, replacing Larry Gold who will continue as chairman of the board and as a full-time employee at the company.

SomaLogic Raises $10M

NEW YORK (GenomeWeb News) – SomaLogic has raised $10 million in equity financing, the company said in a document filed with the US Securities and Exchange Commission on Tuesday.

Agilent and SomaLogic said this week that they have entered an agreement to expand access to SomaLogic's SOMAscan protein biomarker discovery platform by placing it in select academic and contract research centers.

NEW YORK (GenomeWeb News) – Agilent and SomaLogic said today that they have entered an agreement to expand access to Somalogic's SOMAscan protein biomarker discovery platform by placing it in select academic and contract research centers.

On a conference call last month following the release of its Q1 earnings, Vermillion CEO Thomas McLain announced that the company would be taking over from Quest Diagnostics as leader of commercialization efforts for its OVA1 ovarian cancer diagnostic (

Pages

Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.

The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.

One gene regulates hundreds of others to influence facial development, according to New Scientist.

In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.